Timber Pharmaceuticals (TMBR)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	2.52 mm	2.52 mm	2.52 mm	2.52 mm	2.52 mm	2.52 mm
Cash burn (monthly)	885.33 k	479.52 k	1.33 mm	1.22 mm	885.33 k	1.16 mm
Cash used (since last report)	16.85 mm	9.13 mm	25.37 mm	23.30 mm	16.85 mm	22.02 mm
Cash remaining	-14.33 mm	-6.61 mm	-22.85 mm	-20.78 mm	-14.33 mm	-19.50 mm
Runway (months of cash)	-16.2	-13.8	-17.1	-17.0	-16.2	-16.9

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

TMBR institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	1	1	–
Opened positions	0	0
Closed positions	0	0
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	79.92 mm	79.92 mm	–
Total shares	29.63 mm	29.63 mm	–
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Vivo Capital VIII	29.63 mm	$79.92 mm	0.0%

Largest transactions	Shares	Bought/sold	Change
Vivo Capital VIII	29.63 mm	0.00	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

TMBR insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	#Shares	#Remaining
20 Aug 23	John Koconis	Common Stock, par value $0.001 per share	Grant	Acquire A	No	No	70,385	70,785
20 Aug 23	Joseph Lucchese	Common Stock, par value $0.001	Grant	Acquire A	No	No	35,193	35,193
20 Aug 23	Alan Mendelsohn	Common Stock, par value $0.001 per share	Grant	Acquire A	No	No	35,193	35,393

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.